The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Gold nanoparticles offer route to prostate cancer therapy

    Article obtained from Optics.org RSS Feed.

    Clinical trial evaluates Nanospectra Biosciences technology in latest anti-cancer application.

    Sep, 02 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.